Insiders · Profile

GILLIS JONATHAN

CAO and Interim CFO at MapLight Therapeutics. Filing since 15 Apr 2026. CIK 0001709954

Company

Date

Role

Action

Shares

Amount

Of holding

MPLT MapLight Therapeutics, Inc.

17 Jul 2026

CAO and Interim CFO

Sold on a plan

18,469

$694.46K

11.4%

MPLT MapLight Therapeutics, Inc.

16 Jul 2026

CAO and Interim CFO

Sold on a plan

8,455

$311.11K

4.9%

MPLT MapLight Therapeutics, Inc.

15 Jul 2026

CAO and Interim CFO

Sold on a plan

10,055

$367.09K

5.5%

MPLT MapLight Therapeutics, Inc.

28 Apr 2026

CAAO and PAO

Sold on a plan

17,935

$544.32K

9.0%

MPLT MapLight Therapeutics, Inc.

27 Apr 2026

CAAO and PAO

Sold on a plan

51,900

$1.54M

20.7%

MPLT MapLight Therapeutics, Inc.

15 Apr 2026

CAAO and PAO

Sold at will

3,590

$95.53K

1.4%

6 decisions on file.